Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1956 1
1957 1
1958 2
1959 2
1960 2
1961 1
1962 8
1963 14
1964 5
1965 6
1966 7
1967 8
1968 13
1969 10
1970 13
1971 10
1972 17
1973 11
1974 20
1975 15
1976 13
1977 12
1978 11
1979 19
1980 22
1981 17
1982 34
1983 30
1984 27
1985 45
1986 40
1987 48
1988 78
1989 57
1990 70
1991 80
1992 88
1993 105
1994 130
1995 158
1996 166
1997 167
1998 192
1999 206
2000 283
2001 336
2002 376
2003 404
2004 519
2005 679
2006 799
2007 912
2008 1066
2009 1227
2010 1406
2011 1672
2012 1839
2013 2073
2014 2257
2015 2446
2016 2526
2017 2827
2018 3043
2019 3531
2020 4201
2021 4994
2022 5484
2023 5513
2024 6084
2025 3877
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55,747 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial.
Paz-Ares L, Borghaei H, Liu SV, Peters S, Herbst RS, Stencel K, Majem M, Şendur MAN, Czyżewicz G, Caro RB, Lee KH, Johnson ML, Karadurmuş N, Grohé C, Baka S, Csőszi T, Ahn JS, Califano R, Yang TY, Kemal Y, Ballinger M, Cuchelkar V, Graupner V, Lin YC, Chakrabarti D, Bhatt K, Cai G, Iannone R, Reck M; IMforte investigators. Paz-Ares L, et al. Among authors: lin yc. Lancet. 2025 Jun 14;405(10495):2129-2143. doi: 10.1016/S0140-6736(25)01011-6. Epub 2025 Jun 2. Lancet. 2025. PMID: 40473449 Clinical Trial.
Flexible high-entropy functional ceramics.
Dou L, Yang B, Ye X, Zhang Y, Zhu W, Chen H, Jiang Y, Fang B, Lan S, Li Q, Liu Y, Li P, Zhang X, Li S, Zhang Y, Xu W, Zhang X, Wu L, Li X, Wei X, Yu Z, Nan CW, Lin YH. Dou L, et al. Among authors: lin yh. Nat Commun. 2025 Jul 1;16(1):5915. doi: 10.1038/s41467-025-60548-0. Nat Commun. 2025. PMID: 40595520 Free PMC article.
Mechanisms of endothelial senescence and vascular aging.
Li Q, Qian Z, Huang Y, Yang X, Yang J, Xiao N, Liang G, Zhang H, Fu Y, Lin Y, Zhang C, Liu A. Li Q, et al. Among authors: lin y. Biogerontology. 2025 Jun 25;26(4):128. doi: 10.1007/s10522-025-10279-y. Biogerontology. 2025. PMID: 40560245 Review.
US must support chemistry research.
Allen K, Armentrout PB, Berkman C, Boxer SG, Burkart M, Canary JW, Castellano RK, Columbus L, DeRose VJ, Fairbrother H, Ferguson GS, Foley J, Haynes C, Heemstra JM, Jaekle F, Knappenberger K, Kong W, Kaufman LJ, Lambert TH, Lin YS, Liu H, Metz R, Morris A, Murphy CJ, Peczuh M, Pennington W, Pojman JA, Reisman S, Shores M, Spokoyny AM, Szulczewski G, Van Voorhis T, Warren TH, Wang LS, Wysocki V, Zhang J. Allen K, et al. Among authors: lin ys. Science. 2025 Jun 19;388(6753):1282-1283. doi: 10.1126/science.adx8085. Epub 2025 Jun 19. Science. 2025. PMID: 40536957 No abstract available.
Phase separation of TTBK2 and CEP164 is necessary for ciliogenesis.
Chou PC, Lin YH, Lin IH, Lin TY, Huang YC, Hong SR, Ben Chang TJ, Fang Y, Lin Y, Yang TT, Lin YC, Huang JR, Wang WJ. Chou PC, et al. Among authors: lin y, lin yh, lin yc. Cell Rep. 2025 Jun 24;44(6):115810. doi: 10.1016/j.celrep.2025.115810. Epub 2025 Jun 7. Cell Rep. 2025. PMID: 40483689 Free article.
Tin-halide perovskites for light-emitting diodes.
Li XZ, Ye Y, Cao Y, Zhang D, Lin Y, Chang J, Zhu L, Wang N, Huang W, Wang J. Li XZ, et al. Among authors: lin y. Chem Soc Rev. 2025 Jun 19. doi: 10.1039/d5cs00340g. Online ahead of print. Chem Soc Rev. 2025. PMID: 40536039 Review.
The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis.
Hsu CW, Hsu TW, Kao YC, Lin YH, Thompson T, Carvalho AF, Stubbs B, Tseng PT, Yang FC, Tsai CK, Yu CL, Tu YK, Liang CS. Hsu CW, et al. Among authors: lin yh. J Prev Alzheimers Dis. 2025 May 1:100195. doi: 10.1016/j.tjpad.2025.100195. Online ahead of print. J Prev Alzheimers Dis. 2025. PMID: 40316479 Free article.
55,747 results
You have reached the last available page of results. Please see the User Guide for more information.